RNASET2 and posterior cortical atrophy: The low response of PC-3 cells to RNASET2 could therefore stem from their intrinsic molecular characteristics, emphasizing the importance of selecting in vitro models that align with clinical disease features to better understand RNASET2’s role in PCa.